GBT Short Information, Global Blood Therapeutics Inc.

Twenty Trading Day Totals
Total Shorted Volume	2,315,485
Total Actual Volume	14,983,773

Averages
Average Short Volume	115,774
Average Short Percentage	43.58%

Is there a GBT Short Squeeze or Breakout about to happen?

See the GBT Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2021-06-14	41	40.28	41.23	39.98	970,764	92,140	21.1411
2021-06-11	41.72	40.64	41.72	40.1	938,660	119,706	39.5418
2021-06-10	40.42	41.67	41.72	39.86	1,102,796	132,609	25.7879
2021-06-09	41.36	40.42	41.73	40.2137	754,138	155,751	46.2290
2021-06-08	40.05	40.65	40.73	39.4	825,316	140,198	43.1357
2021-06-07	39.04	39.85	40.09	38.26	949,190	164,518	43.9580
2021-06-04	38.48	39	39.77	38.03	729,955	113,277	38.7443
2021-06-03	37.6	38.26	38.38	37.14	582,873	106,896	52.4164
2021-06-02	37.2	37.56	37.64	36.42	814,838	102,927	36.2279
2021-06-01	38.32	37.2	38.383	37.02	843,520	162,478	53.6065
2021-05-28	38.94	38.43	39.93	38.32	727,479	99,953	50.6096
2021-05-27	39.02	38.78	39.33	38.21	633,397	81,961	35.3910
2021-05-26	38.25	39.21	39.38	38.1	586,839	116,170	49.1080
2021-05-25	37.24	38.12	38.235	36.9532	644,326	106,334	55.7628
2021-05-24	38.01	37.23	38.4839	37.15	471,913	47,703	37.8139
2021-05-21	37.85	37.8	38.31	36.61	553,403	78,691	55.8468
2021-05-20	36.47	37.74	38.31	36.47	563,847	98,109	51.3555
2021-05-19	36.82	36.43	37.22	36.01	628,097	84,109	32.3850
2021-05-18	36.38	37.29	38.24	36.04	915,585	187,825	42.0869
2021-05-17	36	36.31	36.7	35.705	746,837	124,130	60.3681

Stock Information

Global Blood Therapeutics Inc. Company Name:

GBT Stock Symbol:

NASDAQ Market:

Get GBT Alerts

News, Short Squeeze, Breakout and More Instantly...

GBT - GBT's Voxelotor is First Sickle Cell Disease Treatment to Receive Promising Innovative Medicine (PIM) Designation in the UK

SOUTH SAN FRANCISCO, Calif. and LONDON, June 14, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT), a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments for underserved patient communities, announced toda...
GBT - New Data Supporting the Potential Use of Oxbryta® (voxelotor) in Children Ages 4 to 11 Years with Sickle Cell Disease Presented at European Hematology Association 2021 Virtual Congress

Analysis from Phase 2a HOPE-KIDS 1 Study Featured in Oral Presentation Two Real-world Data Studies Demonstrated Sustained Improvements in Hemoglobin with Oxbryta Consistent with Results from the Phase 3 HOPE Study SOUTH SAN FRANCISCO, Calif., June 11, 2021 (GLOBE NEWSWIRE)...
GBT - GBT Announces Participation at the Goldman Sachs 42nd Annual Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will participate in a virtual fireside chat at the 42nd Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 8, 2021, at 2:10 p.m...